ASCENSION ST. VINCENT CARMEL — History
CCN 150157 | 3-year financial timeline | COVID resilience: 35/100
🛡️ Public data only — no PHI permitted on this instance.
$268M
Latest Revenue (FY2022)
+4.0%
Revenue CAGR (3yr)
38.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $248M | $249M | $268M | +7.6% | +4.0% |
| Operating Expenses | $142M | $167M | $166M | -1.0% | +8.2% |
| Operating Margin | 42.9% | 33.0% | 38.3% | +16.2% | -5.6% |
| Net Income | $107M | $82M | $103M | +25.0% | -1.8% |
| Licensed Beds | 153 | 124 | 124 | +0.0% | -10.0% |
| Total Patient Days | 21,002 | 22,532 | 22,820 | +1.3% | +4.2% |
| Medicare Day % | 23% | 21% | 19% | -7.3% | -7.8% |
| Medicaid Day % | 3% | 5% | 3% | -32.3% | +3.0% |
COVID Impact & Recovery
Resilience Score: 35/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: +8.3% ($248M → $268M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.0%
This Hospital
+7.6%
State Avg
Latest Margin
38.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $279M | 36.0% |
| FY2024 (proj) | $289M | 33.6% |
| FY2025 (proj) | $299M | 31.3% |